New Clinical Trials for Skin Cancer

Protection against skin cancer is importantWhile a lot is known about the causes of skin cancer, there is a lot to be learned about better ways to treat the disease. More skin cancer clinical studies are needed to develop advanced and sophisticated preventative methods.

There are new skin cancer clinical trials being conducted. If you have been diagnosed with skin cancer and would like to participate in a clinical trial please review the list. Participation in clinical trials is always at no cost to you.

What is Skin Cancer?

Skin cancer is cancer growths that form on the outside layer of the skin. The three most common malignant skin cancers are basal, squammous and melanoma. Since skin cancer develops on the skin it is generally easy to notice and diagnose. Tumors are highly visible in skin cancer. It is the most commonly diagnosed form of cancer and is generally very treatable. Most skin cancer is caused by prolonged exposure to the sun. Sunscreen can help, but it does not help with all types of cancer. Smoking can also cause skin cancer. Patients may first notice a change in skin color and texture and sometimes changes in the appearance of moles indicates that skin cancer is present. It is also known as skin neoplasm. Learn more by visiting the Skin Cancer Foundation.

Skin Cancer Treatments

The best way to treat skin cancer is to prevent it. Limiting exposure to the sun, especially during the peak hours of 10 a.m. – 3 p.m., wearing protective clothing and using sunscreen will all reduce the risk of developing skin cancer. Once developed the skin cancer treatment depends on the type, location, severity, and cause of the skin cancer. Low risk skin cancer treatments include radiation therapy, topical chemotherapy or cryotherapy (freezing off the cancer). There is also a surgery called Moh’s micrographic surgery that is sometimes used to remove the cancer.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Oncology Clinical Trial
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Status: Enrolling
Updated: 12/17/2013
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control
Status: Enrolling
Updated: 12/17/2013
mi
from
Providence, RI
Click here to add this to my saved trials
Melanoma Clinical Trial
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
Status: Enrolling, Phase III
Updated: 12/27/2013
mi
from
Flushing, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Status: Enrolling
Updated: 9/19/2012
mi
from
New York, NY
Click here to add this to my saved trials
Intraocular Melanoma Clinical Trial
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Status: Enrolling, Phase II
Updated: 1/9/2014
mi
from
Encinitas, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase I, II
Updated: 1/9/2014
mi
from
Encinitas, CA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
Status: Enrolling
Updated: 7/16/2012
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Status: Enrolling, Phase I, II
Updated: 10/16/2010
mi
from
Newark, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Status: Enrolling
Updated: 5/20/2015
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Greer, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Elmhurst, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Grand Island, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Hollywood, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Marquette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Media, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Methuen, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Murray, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Oakland, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Ogden, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Orange Village, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Rockford, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Shreveport, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Sioux City, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 2/5/2015
mi
from
Zanesville, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Harvey, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Springfield, IL
Click here to add this to my saved trials
Melanoma Clinical Trial
An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma
Status: Enrolling
Updated: 10/17/2011
mi
from
Boston, MA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Status: Enrolling, Phase II
Updated: 7/2/2014
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
A Study of Intratumoral CAVATAK in Patients With Stage IIIc and Stage IV Malignant Melanoma
Status: Enrolling, Phase II
Updated: 7/2/2014
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Status: Enrolling
Updated: 9/19/2012
mi
from
Baltimore, MD
Click here to add this to my saved trials
Acromegaly Clinical Trial
Lanreotide Levels in Acromegaly
Status: Enrolling
Updated: 6/9/2009
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology, Reproductive Clinical Trial
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
Status: Enrolling
Updated: 11/15/2012
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Columbus, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Denver, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Greenville, SC
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Kinston, NC
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
La Crosse, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Asheboro, NC
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Aurora, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Battle Creek, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Bemidji, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Bismarck, ND
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Bozeman, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Burnsville, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Columbus, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Danville, VA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Dearborn, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Denver, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Des Moines, IA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Duluth, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Edina, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
El Dorado, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Elkhart, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Escanaba, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Eureka, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Glens Falls, NY
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Greenville, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Havana, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Hazleton, PA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Helena, MT
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Hutchinson, MN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Kewanee, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lancaster, OH
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Liberal, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Livonia, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Longmont, CO
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Marinette, WI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Michigan City, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Mishawaka, IN
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Moline, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Monroe, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Muskegon, MI
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Normal, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Oakland, CA
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Omaha, NE
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Parsons, KS
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Peoria, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Peru, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Princeton, IL
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Rapid City, SD
Click here to add this to my saved trials
Melanoma (Skin) Clinical Trial
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Status: Enrolling, Phase II
Updated: 2/21/2013
mi
from
Saint Louis, MO
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 66